Company Analysis

UBS Group AG (UBS)

NYSE: UBS · National Commercial Banks · Zurich, CH · filing with the SEC since 2014
Grade5.7
◀ Past 5.7● Present 4.4▶ Future 7.6
2 est.

Who owns UBS Group AG

As filed with the SEC
Holders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
0
report now, of 0 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
Norges Bank
SCHEDULE 13G/A · filed Apr 14, 2025 · Common Stock · reported falling below 5%
under 5%
What UBS reports owning in othersstakes of 5% or more, and other ties
abrdn Income Credit Strategies Fund
SCHEDULE 13G/A · filed Aug 3, 2026 · 5.250% Series A Perpetual Preferred Shares
30%
Vipshop Holdings Limited VIPS
SCHEDULE 13G/A · filed May 7, 2026 · Class A ordinary shares, par value US$0.0001 per share
20%
Summit Hotel Properties, Inc. INN
8.1%
Nuveen California Municipal Value Fund
6.6%
IHS Holding Limited IHS
SCHEDULE 13G · filed Aug 5, 2026 · Ordinary Shares, par value USD 0.30 per share
5.8%
Thornburg Income Builder Opportunities Trust TBLD
5.6%
Rising Dragon Acquisition Corp. RDAC
5.5%
Amicus Therapeutics, Inc.
SCHEDULE 13G · filed May 7, 2026 · Common Stock, par value $0.01 per share
5.5%
Starlink AI Acquisition Corporation OTAI
SCHEDULE 13G · filed Aug 4, 2026 · Units, each consisting of one ordinary share and one right to receive one-fourth (1/4) of one ordinary share
5.4%
APEX Tech Acquisition Inc.
SCHEDULE 13G · filed May 7, 2026 · Units, each consisting of one ordinary share and one right
5.4%
The other 15
Reviva Pharmaceuticals Holdings, Inc.
SCHEDULE 13G/A · filed Jul 31, 2026 · reported falling below 5%
under 5%
Amc Entertainment Holdings, Inc.
SCHEDULE 13G/A · filed Jul 31, 2026 · reported falling below 5%
under 5%
Rapid7, Inc.
SCHEDULE 13G/A · filed Jul 29, 2025 · reported falling below 5%
under 5%
Renalytix plc
SCHEDULE 13G/A · filed Apr 30, 2025 · reported falling below 5%
under 5%
PIMCO Access Income Fund
SCHEDULE 13G/A · filed Apr 30, 2025 · reported falling below 5%
under 5%
Zeta Network Group
SCHEDULE 13G/A · filed Apr 30, 2025 · reported falling below 5%
under 5%
Infinera Corp
SCHEDULE 13G/A · filed Apr 30, 2025 · reported falling below 5%
under 5%
Clorox Company
SCHEDULE 13G/A · filed Apr 25, 2025 · reported falling below 5%
under 5%
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc.
SCHEDULE 13G/A · filed Oct 30, 2024 · reported falling below 5%
under 5%
Western Asset Investment Grade Defined Opportunity Trust Inc.
SCHEDULE 13G/A · filed May 7, 2026 · reported falling below 5%
under 5%
Liberty Broadband Corporation
SCHEDULE 13G/A · filed Feb 10, 2025 · reported falling below 5%
under 5%
Amneal Pharmaceuticals, Inc.
SCHEDULE 13G/A · filed Feb 10, 2025 · reported falling below 5%
under 5%
Sight Sciences, Inc.
SCHEDULE 13G/A · filed Aug 8, 2024 · reported falling below 5%
under 5%
The Marcus Corporation
SCHEDULE 13G/A · filed Aug 8, 2024 · reported falling below 5%
under 5%
ASLAN Pharmaceuticals Ltd
SCHEDULE 13G/A · filed Aug 8, 2024 · reported falling below 5%
under 5%
Other ties the annual report names
Banco De Investimentos Credit Suisse Brasil SA Subsidiaries
An entity · subsidiary · owns, named in the 20-F filed Mar 9, 2026
Banknow AG Subsidiaries
An entity · subsidiary · owns, named in the 20-F filed Mar 9, 2026
Credit Suisse International Subsidiaries
An entity · subsidiary · owns, named in the 20-F filed Mar 9, 2026
Credit Suisse International Subsidiaries Reporting Entity Ownership
An entity · subsidiary · owns, named in the 20-F filed Mar 9, 2026
Credit Suisse Securities China Limited Subsidiaries
An entity · subsidiary · owns, named in the 20-F filed Mar 9, 2026
Credit Suisse USA LLC Subsidiaries
An entity · subsidiary · owns, named in the 20-F filed Mar 9, 2026
UBS AG Subsidiaries
An entity · subsidiary · owns, named in the 20-F filed Mar 9, 2026
UBS Americas Holding LLC Subsidiaries
An entity · subsidiary · owns, named in the 20-F filed Mar 9, 2026

Its Form 13F-HR for Jun 30, 2026 lists 10,407 holdings. The record carries no value for them.

Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton UBS · research, not advice